Self- and Partner-Reported Subjective Memory Complaints: Association with Objective Cognitive Impairment and Risk of Decline.

Autor:	Zuroff L; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wisse LE; Department of Diagnostic Radiology, Lund University, Lund, Sweden., Glenn T; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Xie SX; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, USA., Nasrallah IM; Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA.; Center for Biomedical Image Computing and Analytics, University of Pennsylvania, Philadelphia, PA, USA., Habes M; Neuroimage Analytics Laboratory (NAL) and the Biggs Institute Neuroimaging Core (BINC), Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center San Antonio (UTHSCSA), San Antonio, TX, USA., Dubroff J; Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA., de Flores R; Université de Caen Normandie, INSERM UMRS U1237, Caen, France., Xie L; Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA., Yushkevich P; Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA., Doshi J; Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA.; Center for Biomedical Image Computing and Analytics, University of Pennsylvania, Philadelphia, PA, USA., Davatsikos C; Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA.; Center for Biomedical Image Computing and Analytics, University of Pennsylvania, Philadelphia, PA, USA., Shaw LM; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Tropea TF; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Chen-Plotkin AS; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wolk DA; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Das S; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Mechanic-Hamilton D; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jazyk:	angličtina
Zdroj:	Journal of Alzheimer's disease reports [J Alzheimers Dis Rep] 2022 Jul 22; Vol. 6 (1), pp. 411-430. Date of Electronic Publication: 2022 Jul 22 (Print Publication: 2022).
DOI:	10.3233/ADR-220013
Abstrakt:	Background: Episodic memory decline is a hallmark of Alzheimer's disease (AD). Subjective memory complaints (SMCs) may represent one of the earliest signs of impending cognitive decline. The degree to which self- or partner-reported SMCs predict cognitive change remains unclear. Objective: We aimed to evaluate the relationship between self- and partner-reported SMCs, objective cognitive performance, AD biomarkers, and risk of future decline in a well-characterized longitudinal memory center cohort. We also evaluated whether study partner characteristics influence reports of SMCs. Methods: 758 participants and 690 study partners were recruited from the Penn Alzheimer's Disease Research Center Clinical Core. Participants included those with Normal Cognition, Mild Cognitive Impairment, and AD. SMCs were measured using the Prospective and Retrospective Memory Questionnaire (PRMQ), and were evaluated for their association with cognition, genetic, plasma, and neuroimaging biomarkers of AD, cognitive and functional decline, and diagnostic progression over an average of four years. Results: We found that partner-reported SMCs were more consistent with cognitive test performance and increasing symptom severity than self-reported SMCs. Partner-reported SMCs showed stronger correlations with AD-associated brain atrophy, plasma biomarkers of neurodegeneration, and longitudinal cognitive and functional decline. A 10-point increase on baseline PRMQ increased the annual risk of diagnostic progression by approximately 70%. Study partner demographics and relationship to participants influenced reports of SMCs in AD participants only. Conclusion: Partner-reported SMCs, using the PRMQ, have a stronger relationship with the neuroanatomic and cognitive changes associated with AD than patient-reported SMCs. Further work is needed to evaluate whether SMCs could be used to screen for future decline. Competing Interests: IMN receives compensation as an educational speaker for Biogen. LX received personal consulting fees from Galileo CDS, Inc. All other authors have no relevant conflics of interest to report. (© 2022 – The authors. Published by IOS Press.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu